March 23, 2018
CareDx (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
May 23, 2017
ChemoCentryx announced the European Medicines Agency granted avacopan an orphan medical designation for the treatment of patients with C3 glomerulopathy.
April 18, 2017
Prometic Life Sciences received approval from the US Food and Drug Administration for the PBI-4050 Phase 2/3 clinical trials.
April 10, 2017
Anthera Pharmaceuticals completed the dosing of a recent randomized, double-blind, placebo-controlled clinical study of blisibimod on patients with Berger's disease.
February 13, 2017
Nano Dimension (TASE:NNDM,NASDAQ:NNDM), announced today that it intends to create a platform for 3D bio-printing of cells and connective tissues...
November 23, 2016
We’re looking ahead to some innovative medical devices arriving in 2017 and beyond—namely, a series of ‘artificial organs’ that imitate...
October 15, 2016
Pfizer announced that three abstracts for XELJANZ®, being investigated in moderate to severe ulcerative colitis (UC), will be presented at...